177lu lu psma 617 (Novartis)
86
Structured Review
Novartis
177lu lu psma 617
177lu Lu Psma 617, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/177lu+psma+617/177+617+lu+lu+psma/pm42167807-72-10-12
Average 86 stars, based on 1 article reviews
177lu Lu Psma 617, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/177lu+psma+617/177+617+lu+lu+psma/pm42167807-72-10-12
Average 86 stars, based on 1 article reviews
177lu lu psma 617 - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Diagnostic Assay:Article Title: Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer Article Snippet: .. For small targeting moieties, the most commonly used companion diagnostic radionuclide is gallium-68 [68Ga] for PET, such as for benchmark TRT Positron Emission Tomography:Article Title: Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer Article Snippet: .. For small targeting moieties, the most commonly used companion diagnostic radionuclide is gallium-68 [68Ga] for PET, such as for benchmark TRT Selection:Article Title: Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer Article Snippet: .. For small targeting moieties, the most commonly used companion diagnostic radionuclide is gallium-68 [68Ga] for PET, such as for benchmark TRT other:Article Title: Summary: SNMMI/ACNM Procedure Standard for Posttreatment Imaging of 177 Lu-Based Radiopharmaceuticals. Article Snippet: Molecular Imaging and Therapy, BC Cancer, Vancouver, British Columbia, Canada; Basic and Translational Research, BC Cancer Research Institute, Vancouver, British Columbia Canada; Department of Radiology, University of British Columbia, Vancouver, British Columbia Canada; Department of Radiology, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medical Imaging, Division of Nuclear Medicine and Theranostics, University of Arizona and Banner University Medical Center—Tucson, Tucson, Arizona; Radiology, Brigham and Women’s Hospital; Imaging, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Department of Radiology, University of Iowa, Iowa City, Iowa; Department of Radiation Oncology, University of Iowa, Iowa City, Iowa; Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa; Department of Radiology, University of Michigan, Ann Arbor, Michigan; California Pacific Medical Center, San Francisco, California; and Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California |